The CCTS recognizes the importance of ensuring quality data and human subject
protection in clinical research.
We partner with our investigators to assist in achieving this by providing ongoing support,
education, study management tools and best practice recommendations.
What qualifies a study for QA/QI review?
When you accept CCTS support or services on your investigator initiated, human clinical protocol, it may fall under the CCTS Quality Improvement program.
Studies that fall under the purview of the CCTS QA/QI program include investigator initiated, human clinical studies with the following:
- Studies with funding from the CCTS pilot, KL2, or TL1 programs
- Studies being reviewed by the CCTS Data
- Safety Monitoring Board (DSMB)
- Studies utilizing the following CCTS services
- Clinical Research Unit (CRU)
- Regulatory Knowledge and Support
- Functional Assessment and Body Composition (FAABC)
- Biomarker Analysis Lab (BAL) if your study is a prospective study
How do I get started?
It’s easy! If your study qualifies for QA/QI review, contact the Quality Improvement Team after enrolling your first participant and they will schedule your visit.
What will be reviewed during your visit?
The visit will be focused on educational opportunities related to Good Clinical
Practice (GCP). Your participant and regulatory study documentation will be
reviewed. There is nothing to prepare for, however you will want to have your study
documentation readily available for the reviewer.
What are the benefits of a QA/QI review?
- Protecting Human Subjects
Our #1 priority is our Subjects and ensuring they are participating in quality research that respects their rights as research subjects.
- Quality Research
The QA/QI program offers an opportunity for you to receive feedback on your protocol and address any areas of weakness before they become an issue. Our QA/QI specialist has many years of experience and can help you work through any potential problems that may be identified.
The CCTS partners with other research entities including Markey Cancer Center (MCC) and Office of Research Integrity (ORI) on campus to identify areas that might benefit from additional education. We design our educational opportunities based on this feedback received through our QA/QI program and from our investigators. You are helping to shape the future of research at UK with your participation.
Other things you should know
- QA/QI is an opportunity for you and your study team to receive input on ways to ensure your study is successful.
- We will work with you to address any areas that may be identified as needing improvement.
- Education and continuous improvement initiatives are based on outcomes from the QA/QI program.
Please note the 2019 holiday schedule for CCTS Regulatory office:
• Thursday, Nov. 28 (Thanksgiving Day) – Regulatory Unit Closed
• Friday, Nov. 29 (day after Thanksgiving) – Regulatory Unit Closed
• Friday, Dec. 13th – the Regulatory Unit Closed after 1pm for a CCTS function
• Monday, Dec. 23 - Wednesday, Jan. 1 Regulatory Unit Closed (Reopening Thursday, Jan. 2)
• We realize this extended closure may be inconvenient for you and may affect your study schedules. If you have questions, need further clarification, or if any of the above presents a problem to you or your research team, please contact Laura Ashe at (859) 323-2782 or Laura.Ashe@uky.edu no later than November 29, 2019.
• With the cold weather coming soon, we want you to be aware, that if the University announces planned delays or closures (Plan B), the regulatory unit will operate on the delayed schedule or will be closed.